Navigation Links
Applied nanobiomedicine: Exploiting nanoparticles to hunt for hidden cancer cells

The German Federal Ministry of Education and Research provides over 300,000 for the next three years to fund a new research project at the Mainz University Medical Center. The project aims to detect dispersed tumor cells in cancer patients. Latest reports indicate that such detached cancer cells could play an important role for the early detection of cancer. Also, they may provide important information whether patients are indeed responding to therapy. To overcome the current limitations precluding the routine detection of these rare cells, the research network seeks to exploit a novel combination of nanotechnology combined with principles underlying hard drive technology. The research team headed by Professor Dr. Roland Stauber of the Department of Otolaryngology, Head, and Neck Surgery at the Mainz University Medical Center is embedded in the recently initiated "Magnetic Flow Cytometry" (MRCyte) project.

Almost all forms of cancer occur much more frequently in older patients than in younger people. Demographic changes and the general increase in life expectancy mean that individuals are at increased risk of developing cancer. According to the Cancer Information Service (KID) of the German Cancer Research Center, it is expected that some 486,000 new cases of cancer will be reported in Germany in 2012. Despite innovative treatments and the fact that more and more people survive their illness, cancer is still one of the most common causes of death in Germany due to its increased prevalence.

In addition to the development of novel cancer treatment strategies, early disease detection and the monitoring of patient response is highly effective in reducing mortality. "Latest findings seem to indicate that dispersed tumor cells are actually an early warning signal not only of cancer development but also of relapse following therapy," explains project manager Professor Roland Stauber. The detection of such tumor cells in the blood of cancer patients is thus of particular interest in terms of both diagnosis and prognosis. However, before this knowledge can be exploited routinely in the clinics, the development of reliable and easy-to-use detection systems is a must. Such devices need to ensure that isolated tumor cells can be reliable and dynamically detected without the need for complex prior sample preparation. Hence, during the new research project, the researchers in Mainz and their collaborative partners from industry and academia are aiming at the development of a method that allows the concentration of rare cells in patients' blood by a novel combination of nanoparticle-based magnetic flow cytometry combined with hard drive read head detection technology. "Early detection is still the crucial factor in the fight against cancer. The strategy adopted in the MRCyte joint project is tremendously innovative and could well open up new dimensions for future treatment concepts," explains the Scientific Director of the Mainz University Medical Center, Professor Dr. Dr. Reinhard Urban.

Still, one of the main challenges prior to applying the research results from "bench to bedside" is based on the fact that cancer cells can vastly differ in terms of appearance, size, and composition compared to their healthy "sister" cells. This makes it even more difficult to reliably detect detached tumor cells. "Clearly, before our approach can be used on patients, extensive laboratory research is required," emphasizes Stauber. "Fortunately, our experience and developed technologies obtained during a previous project supported by the Rhineland-Palatinate Trust for Innovation will help us to rationally address these caveats in order to further improve patients' care procedures," Professor Roland Stauber is confidently looking ahead. The funding will therefore provide a decisive impetus for the implementation of innovative projects with a high practical relevance.

Contact: Professor Dr. Roland H. Stauber
Johannes Gutenberg Universitaet Mainz

Related medicine news :

1. Applied Optics focus issue: Digital holography and 3-D imaging
2. Black Box Drug Warning Labels Applied Inconsistently: Study
3. Trauma surgeon leads call to action for pediatric applied trauma research network
4. Applied nuclear physics for biomedicine, nuclear security and basic science
5. Verdict Search recognizes Applied Forensics in Top 25 New York Verdicts of 2009
6. Evidence-based medicine theory can be applied to frequent flying says US professor
7. HOGGAN Ergo to Debut New Software and Sensor at the 2010 Applied Ergonomics Conference
8. Exploiting the architecture of cancers may lead to their destruction
9. Nanoparticles may enhance cancer therapy
10. Children may have highest exposure to titanium dioxide nanoparticles
11. UC Davis researchers refine nanoparticles for more accurate delivery of cancer drugs
Post Your Comments:
(Date:11/27/2015)... LOS ANGELES, CA (PRWEB) , ... November 27, 2015 , ... MPWH, the No.1 Herpes-only ... age of 30 (see Table 1-1 ). More than 3.7 billion people under ... simplex virus type 1 (HSV-1), according to WHO's first global estimates of HSV-1 infection ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... Secura Consultants has prided itself for not only fulfilling the needs of advisers ... solutions at an affordable price and providing top-tier customer service. However, there's always ...
(Date:11/27/2015)... ... November 27, 2015 , ... Dr. Thomas Dunlap and ... Dr. Tucker Bierbaum with Emergency Medicine at St., Joseph Health System’s Santa Rosa ... Sepsis conditions present in similar ways and require time-critical intervention to avoid large area ...
(Date:11/26/2015)... ... 26, 2015 , ... Inevitably when people think Thanksgiving, they also think Holiday ... the Black Friday and Cyber Monday massage chair sales to receive the ... and low to find the best massage chair deals, they can see all of ...
(Date:11/26/2015)... ... ... Jobs in hospital medical laboratories and in the imaging field lead the many ... Medical Group . These fields, as well as travel nursing, ranked at ... through the company’s website, , The leading healthcare staffing agency released ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... Nov. 25, 2015  Amgen (NASDAQ: AMGN ) ... (BLA) with the United States ... a biosimilar candidate to Humira ® (adalimumab). Amgen ... submitted to the FDA and represents Amgen,s first BLA ... E. Harper , M.D., executive vice president of Research ...
(Date:11/25/2015)... N.Y. , Nov. 25, 2015  Linden Care, ... and optimizing treatment outcomes for patients suffering from chronic ... request for a Temporary Restraining Order (TRO) enjoining Express ... the two companies. --> ... pursuing all of its legal options. ...
(Date:11/25/2015)... On Tuesday, November 24, 2015, the ... Wright Medical Technology, Inc. for product liability and ... implant device, awarded $11 million in favor of ... and three days of deliberations, the jury found ... designed and unreasonably dangerous, and that Wright Medical ...
Breaking Medicine Technology: